InvestorsHub Logo
Followers 91
Posts 5592
Boards Moderated 0
Alias Born 06/05/2008

Re: None

Thursday, 12/03/2020 7:55:30 PM

Thursday, December 03, 2020 7:55:30 PM

Post# of 3896
THE CLOCK IS TICKING

on the results of this news that came out about three weeks ago (11/17/20):

“ RedHill Biopharma Ltd. (RDHL Quick QuoteRDHL - Free Report) announced that it has completed enrollment in the phase II study on opaganib (Yeliva, ABC294640) in patients hospitalized with severe COVID-19 pneumonia. Top-line data from the study are expected in the coming weeks...”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News